A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer. (Q41474859)
Jump to navigation
Jump to search
scientific article published on 14 August 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer. |
scientific article published on 14 August 2015 |
Statements
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer (English)
L A Bazhenova
J Nemunaitis
M Tan
E Juhász
M M van den Heuvel
R Lal
G H Kloecker
K D Eaton
Q Chu
D J Dunlop
M Jain
E B Garon
C S Davis
E Carrier
S C Moses
D L Shawler